secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0001299130-26-000012
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pacific Biosciences CEO and COO swap interim responsibilities effective Jan 28, 2026
--------------------------------------------------------------------------------

- CEO Christian Henry assumes interim oversight of operations and R&D from COO Mark Van Oene.
- COO Mark Van Oene assumes interim oversight of sales and customer support from CEO Christian Henry.
- No changes to titles or compensation for either executive as a result of the reassignment.
- Effective date of role adjustment: January 28, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000129913026000012/0001299130-26-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000129913026000012/pacb-20260128.htm
  HTML page:      https://secwatch.observer/filing/0001299130-26-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer